回顾：临床试验结果

Assessing nocturia in clinical trials

Svetlana Avulova , Jeffrey P Weiss

• 抽象的

研究文章

Experience in international clinical research: the HIV Prevention Trials Network

Nirupama Deshmane Sista, Quarraisha Abdool Karim, Kathy Hinson, Deborah Donnell, Susan H Eshleman,Sten H ermund

• 抽象的

会议记录

miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma

Krishan Jethwa, Jun Wei, Kayla McEnery & Amy B Heimberger

• 抽象的

评论文章

JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data

Raoul Tibes, Ruben Mesa

• 抽象的

临床试验结果

Design of clinical trials for biomarker research in oncology

Sumithra J Mandrekar, Daniel J Sargent

• 抽象的

研究文章

Incentives and barriers to neurological clinical research participation

Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie

• 抽象的

评论文章

Clinical trials in idiopathic pulmonary fibrosis: update and perspectives

Eva Baroke, Shyam Maharaj, Martin Kolb

• 抽象的

患者视角

miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma

Krishan Jethwa, Jun Wei, Kayla McEnery,Amy B Heimberger

• 抽象的

治疗前景

Anti-angiogenic therapy for prostate cancer: rationale and ongoing trials

Bamidele A Adesunloye, William L Dahut

• 抽象的

评论文章

Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data

Brendan Boyce, Lianping Xing

• 抽象的

评论文章

Boceprevir in the treatment of hepatitis C infection: rationale and clinical data

Omer Khalid ,Bruce R Bacon

• 抽象的